Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Central Nervous System Neoplasms 6Astrocytoma 5Oligodendroglioma 4Optic Nerve Glioma 3Medulloblastoma 3Gliosarcoma 3Glioblastoma 3Familial ependymoma 3Choroid Plexus Neoplasms 3Lymphoma, T-Cell, Cutaneous 2Brain Neoplasms 2Wilms Tumor 1Unspecified Adult Solid Tumor, Protocol Specific 1Testicular Neoplasms 1Teratoma 1Sezary Syndrome 1Sarcoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Mycosis Fungoides 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Glioma 1Ependymoma 1

Interventions

tanespimycin 4fludarabine phosphate 4Magnetic Resonance Spectroscopy 4Cyclosporine 4Biopsy 4aldesleukin 3Vorinostat 3Specimen Handling 3Polymerase Chain Reaction 3Peripheral Blood Stem Cell Transplantation 3Irinotecan 3Gemcitabine 3Flow Cytometry 3Bortezomib 3romidepsin 2pembrolizumab 2nelarabine 2mogamulizumab 2laromustine 2entinostat 2belinostat 2alvocidib 2Psychiatric Rehabilitation 2Pharmacogenomic Testing 2Nivolumab 2Methylprednisolone 2MK 2206 2Levofloxacin 2Lenalidomide 2Interleukin-15 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Sezary Syndrome × O(6)-benzylguanine × Clear all
NCT00961220 2018-05-22

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 1/2 Completed
17 enrolled 6 charts
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡